Evidence map›Paper›PMID 29253901›Full record

ArticlePloS one2017

Single molecule sequencing of the M13 virus genome without amplification.

Luyang Zhao, Liwei Deng, Gailing Li, Huan Jin, Jinsen Cai, Huan Shang, Yan Li, Haomin Wu, Weibin Xu, Lidong Zeng and 10 more

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Luyang ZhaoDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Liwei DengDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Gailing LiDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Huan JinDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Jinsen CaiDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Huan ShangDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Yan LiDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Haomin WuDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Weibin XuDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Lidong ZengDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Renli ZhangReproductive Medical Center of Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China.
Huan ZhaoShenzhen Armed Police Hospital Reproductive Center, Luohu District, Shenzhen, China.
Ping WuDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Zhiliang ZhouDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Jiao ZhengDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Pierre EzannoDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Andrew X YangDepartment of Biology, South University of Science and Technology of China, Shenzhen, Guangdong, China.
Qin YanDirect Genomics Co., Ltd., Shenzhen, Guangdong, China.
Michael W DeemDepartments of Bioengineering and Physics & Astronomy, Rice University, Houston, TX, United States of America.
Jiankui HeDepartment of Biology, South University of Science and Technology of China, Shenzhen, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Next generation sequencing (NGS) has revolutionized life sciences research. However, GC bias and costly, time-intensive library preparation make NGS an ill fit for increasing sequencing demands in the clinic. A new class of third-generation sequencing platforms has arrived to meet this need, capable of directly measuring DNA and RNA sequences at the single-molecule level without amplification. Here, we use the new GenoCare single-molecule sequencing platform from Direct Genomics to sequence the genome of the M13 virus. Our platform detects single-molecule fluorescence by total internal reflection microscopy, with sequencing-by-synthesis chemistry. We sequenced the genome of M13 to a depth of 316x, with 100% coverage. We determined a consensus sequence accuracy of 100%. In contrast to GC bias inherent to NGS results, we demonstrated that our single-molecule sequencing method yields minimal GC bias.

Indexed as

Genome, ViralNucleic Acid Amplification TechniquesBacteriophage M13Base CompositionBase SequenceHigh-Throughput Nucleotide Sequencing

Identifiers

PMID29253901
PMCPMC5734777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.